Neurelis

Neurelis®: Helping More People Define Their Neu Normal

San Diego, United States · Founded 2007 · $314.0M raised

Employees
51–200
Founded
2007
Business Model
B2B
Total Funding
$314.0M
Last Round
$114.0M Series DJun 2023
Rounds
5

About

Neurelis is a commercial-stage neuroscience company founded in 2007 in San Diego, focused on developing and commercializing therapeutics for epilepsy and central nervous system disorders. Its flagship product, approved by the FDA, leverages proprietary Intravail absorption technology and has achieved coverage of over 285 million insured US lives.

Summary

Neurelis is a Biotech company based in San Diego, United States, founded in 2007. It has raised $314.0M in total across 5 rounds, most recently a $114.0M Series D round in Jun 2023. Investors include HBM Healthcare Investments, Cormorant and OrbiMed.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJun 2023
$200.0M

Sign up to see all 6 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neurelis on Indexed.vc
<a href="https://indexed.vc/companies/neurelis-inc"><img src="https://indexed.vc/api/badge/company/neurelis-inc" alt="Neurelis on Indexed.vc" width="260" height="76" /></a>